Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Content Group is a leading Italian Contract Development and Manufacturing Organization (CDMO) specializing in the development and production of medical devices and pharmaceutical products. The group was formed through the strategic integration of COC Farmaceutici and Lameplast, combining decades of expertise in formulation, primary packaging, and contract manufacturing. Content Group focuses on high-growth therapeutic areas including ophthalmology, respiratory health, and dermatology, offering specialized solutions such as single-dose and multi-dose plastic containers. With multiple manufacturing sites in Italy, the company provides end-to-end services from R&D and clinical trial support to large-scale commercial manufacturing. Content Group is currently a portfolio company of the private equity firm Aksìa Group.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Content Group.